Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Norwegian Hydrogen Specialist Nel Navigates Challenging Market Conditions

Robert Sasse by Robert Sasse
November 1, 2025
in Earnings, European Markets, Hydrogen, Renewable Energy
0
Nel ASA Stock
0
SHARES
15
VIEWS
Share on FacebookShare on Twitter

Nel ASA, the Norwegian hydrogen technology company, finds itself navigating turbulent market conditions as its latest quarterly results reveal a complex financial landscape. The third-quarter figures present a tale of two narratives: substantial improvements in profitability stand in stark contrast to significant declines in both revenue and new order intake.

Financial Performance: A Mixed Picture

The company reported revenues of 303 million Norwegian kroner, representing a 17 percent year-over-year decrease. However, a sequential comparison reveals a more encouraging trend, with sales climbing 74 percent from the previous quarter. On the profitability front, Nel demonstrated marked improvement, with EBITDA reaching negative 37 million NOK compared to negative 90 million NOK during the same period last year. The net loss also narrowed considerably, shrinking from 115 million to 85 million NOK year-over-year.

Order Book Contraction Raises Concerns

Perhaps the most concerning aspect of the report was the dramatic contraction in new business. Order intake plummeted to just 57 million NOK, representing a 64 percent decline compared to the previous year. The company’s order backlog similarly diminished, contracting 47 percent over twelve months to stand at 984 million NOK. These figures reflect the cautious investment sentiment currently prevailing within the green hydrogen sector.

Despite these operational headwinds, Nel maintains a solid financial foundation. The company possesses liquid assets of approximately 1.8 billion NOK, providing a buffer against current market challenges. Nevertheless, investors on the Oslo Stock Exchange responded negatively to the mixed report, sending shares lower.

Should investors sell immediately? Or is it worth buying Nel ASA?

Regulatory Landscape Impedes Growth

Company leadership pointed to a “challenging macroeconomic environment” and an electrolyzer market developing more slowly than anticipated. Particularly stringent regulatory barriers across European markets are currently hampering the advancement of hydrogen production initiatives.

In response to these market dynamics, Nel is intensifying its focus on technological innovation. The company is developing a new pressurized alkaline solution scheduled for market release in the first half of 2026, which aims to substantially reduce hydrogen project costs. Simultaneously, Nel is expanding its collaborative efforts with industrial partners including General Motors, Reliance, and Samsung E&A.

Future Prospects and Market Sentiment

Management maintains an optimistic outlook despite the sluggish order intake. They note that Front-End Engineering and Design (FEED) activities continue at relatively robust levels, suggesting potential future orders should market conditions improve.

Market analysts continue monitoring Nel’s progress, with Kepler Cheuvreux recently raising its price target for the company’s shares. The investment community now awaits signals of market recovery and the successful implementation of new technologies in 2026. The company’s next quarterly report is scheduled for release on March 4, 2026.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from March 25 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Talphera Stock
Analysis

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Next Post
BYD Stock

BYD Shares Under Pressure Following Steep Profit Decline

Ethereum Stock

Ethereum at a Critical Juncture: Key Decision Point Approaches

Metaplanet Stock

Japanese Firm Metaplanet Pioneers Bitcoin-Backed Share Buyback Strategy

Recommended

Finance_ People trading stocks

Analyst Upgrades QuinStreet Stock to Strong Buy with Increased Price Target

2 years ago
Trimble Stock

Trimble Stock: A Study in Contrasting Signals

7 months ago
Regency Centers Stock

Regency Centers Stock: Strong Dividend Hike Meets Market Skepticism

5 months ago
Cardinal Health Stock

Cardinal Health Shares Test Key Support Level Amid Sector Uncertainty

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Trending

Coherent Stock
AI & Quantum Computing

Coherent Stock Accelerates Toward New Highs on Key Breakthroughs

by Kennethcix
March 25, 2026
0

Shares of Coherent surged this week, propelled by a landmark technological demonstration and significant corporate developments that...

Corning Stock

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Dell Stock

Dell’s Quantum Security Push Amidst AI-Driven Growth

March 25, 2026
Gossamer Bio Stock

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Coherent Stock Accelerates Toward New Highs on Key Breakthroughs
  • Corning’s Strategic Alliance with Meta Fuels Investor Confidence
  • Dell’s Quantum Security Push Amidst AI-Driven Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com